Abstract:Objective To investigate the effects of hemodialysis combined with hemopurification and comprehensive nursing intervention on the levels of interleukin -6 (IL-6), C-reactive protein (CRP) and β2- microglobulin (β2- MG) in patients with diabetic nephropathy (DN). Methods A total of 68 patients with DN were selected in our hospital, and were treated with hemodialysis combined with hemopurification. The control group was treated with routine nursing intervention, and the observation group was given comprehensive nursing intervention, with 34 cases in each group. The differences in the levels of IL- 6, CRP and β2- MG before and after treatment were compared between the two groups. Results In the control group, the level of IL-6 before treatment [(121.85±34.95) pg/ml] and 1 month after treatment [(120.53 ± 24.95) pg/ml] and 3 months [(119.05 ± 25.73) pg/ml] showed no significant difference (P>0.05). The level of IL-6 in the observation group for 1 month after treatment [(98.90±20.52) pg/ml] and 3 months [(70.32 ± 10.43) pg/ml] was significantly lower than that before treatment, and significantly lower than those in the control group (P<0.05). There was no significant difference in the level of CRPbetween the control group before treatment [(12.64 ± 3.08) mg/L] and 1 month after treatment (12.64±3.15) mg/L] and 3 months [12.89±4.02] mg/L] (P>0.05); the level of CRP at 1 month after treatment [(9.24 ± 3.24)mg/L] and 3 months after treatment [(7.04 ± 2.54)mg/L] in the observation group was significantly lower than that before the treatment, and significantly lower than those in the control group (P<0.05).The level of β2-MG in the control group at 1 month [(10.24±1.79) mg/L] and 3 months after treatment [(9.01 ± 1.47) mg/L] were significantly lower than before the treatment (12.53 ± 3.45) mg/L];thelevel of β2-MG at 1 month [(9.03±1.68) mg/L] and 3 months after treatment [(6.73±1.73)mg/L] in the observation group was also significantly lower thanthat before the treatment, and significantly lower than those in the control group (P<0.05). Conclusions Hemodialysis combined with hemopurification and comprehensive nursing intervention can effectively inhibit the release of inflammatory factors and reduce the inflammatory state, so it has good clinical application value.

The Influence of Atorvastatin for the Renal Function Related Serum Indexes and Renal Fibrosis of Patients with DN

Clinical Observation about Effection of Atorvastatin on Preventing Renal Function in Patients with Coronary Heart Disease and Diabetes Mellitus

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Atorvastatin for the Treatment of Early Diabetic Nephropathy:Clinical Observation

Effect of Atorvastatin on Blood Pressure in Spontaneously Hypertensive Rats

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

Effect of Atorvastatin on HMG -Coa Reductase Expression in Spontaneously Hypertensive Rats

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

Effect of atorvastatin on decreasing a hypertensive response to exercise and improving exercise tolerance

Effect of atorvastatin on NF-κB in peripheral blood mononuclear cells and renal tissues in diabetic rats

Effect of Simvastatin on the Excretion of Urine Microalbuminuria, TGFβ1, Type Ⅳ Collagen and Laminin in Patients with Diabetic Nephropathy

Prostaglandin E1 in treatment of patients with early diabetic nephropathy

The Effects of Atorvastatin on Left Ventricular Remodeling in Spontaneously Hypertensive Rats

Effect of Atorvastatin combined with Irbesartan in the treatment of early diabetic nephropathy

Effect of Simvastatin on expression and excretion of connective tissue growth factor in renal tissue and urinary of diabetic rats

Effect of hemodialysis combined with blood perfusion and comprehensive nursing intervention on the levels of interleukin-6, C-reactive protein and β2-microglobulin in patients with diabetic nephropathy

Relationship Between Expression of Α Smooth Muscle Actin and Diabetic Nephropathy in Rats

Effects of Atorvastatin on Vascular Remodeling in Spontaneously Hypertensive Rats

The Effect of Simvastatin on the Urinary Protein Excretion of Diabetic Rats

The Effect of Simvastatin on the Renal Protection and the Urinary VEGF Excretion in Diabetic Rats

Effect of Simvastatin on the Renal Injury of Diabetic Rats and Excretion of Urine TGF-β1